Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
1dUNwtUhBYFTzPtb